Public Awareness

Baxter Investors Urged to Seek Lead Role in Novum Pump Securities Cases Before Dec. 15 Deadline

Filings cite alleged concealment of Novum infusion‑pump defects that preceded a shipment pause, triggering a sharp share decline.